Drug Shortage Report for BLEOMYCIN FOR INJECTION USP
Report ID | 212050 |
Drug Identification Number | 02131692 |
Brand name | BLEOMYCIN FOR INJECTION USP |
Common or Proper name | BLEOMYCIN FOR INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | BLEOMYCIN |
Strength(s) | 15UNIT |
Dosage form(s) | POWDER FOR SOLUTION |
Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR INTRACAVITARY INTRA-ARTERIAL SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR INTRACAVITARY INTRA-ARTERIAL |
Packaging size | 15IU vial |
ATC code | L01DC |
ATC description | CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2024-01-18 |
Estimated end date | |
Actual end date | 2024-04-09 |
Shortage status | Resolved |
Updated date | 2024-04-10 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2023-11-30 | English | Compare |
v2 | 2023-11-30 | English | Compare |
v3 | 2023-11-30 | French | Compare |
v4 | 2024-01-13 | English | Compare |
v5 | 2024-01-18 | English | Compare |
v6 | 2024-01-18 | French | Compare |
v7 | 2024-01-19 | English | Compare |
v8 | 2024-02-15 | English | Compare |
v9 | 2024-02-15 | French | Compare |
v10 | 2024-03-04 | English | Compare |
v11 | 2024-03-04 | French | Compare |
v12 | 2024-03-22 | English | Compare |
v13 | 2024-03-22 | French | Compare |
v14 | 2024-04-10 | English | Compare |
v15 | 2024-04-10 | French | Compare |
Showing 1 to 15 of 15